Loading…

Browse All Grants

99,167 grants found

Filters
Reset

Showing 1,1811,200 of 99,167 grants

Active NON-SBIR/STTR RPGS
A Pilot Feasibility HIV prevention Study Linking Incarcerated Women to Post-Release Pre-exposure prophylaxis (PrEP) Services
NATIONAL INSTITUTE OF MENTAL HEALTH University of North Carolina Chapel Hill United States 2024 – 2027

ABSTRACT This application proposes to adapt a Formerly Incarcerated Transitions (FIT) program for mostly African American women, often with health disparities, who are released fro...

$6.78M
USD
Active NON-SBIR/STTR RPGS
Targeting GTP Cyclohydrolase 1 for treating chronic orofacial pain
NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEAR... University of Florida United States 2024 – 2026

PROJECT SUMMARY Chronic pain is a global healthcare problem that reduces the quality of patients’ lives and increases med- ical expenditures. Inadequate pain control with available...

$4.19M
USD
Active NON-SBIR/STTR RPGS
Effect of the plantar skin microenvironment on tumor metastasis and drug tolerance
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2024 – 2029

Project Summary Patients with advanced acral melanoma (AM) suffer worse outcomes relative to patients with cutaneous melanoma (CM), in part, because they do not respond as well to...

$4.26M
USD
Active NON-SBIR/STTR RPGS
Impact of seizure onset pattern on temporal lobe seizure propagation through the basal ganglia
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND S... Emory University United States 2024 – 2029

SUMMARY The objective of this proposal is to investigate how temporal lobe (TL) seizures with different onset patterns propagate through the basal ganglia (BG) and to evaluate the...

$6.74M
USD
Active NON-SBIR/STTR RPGS
Vaccines and Therapeutic Antibodies to Respiro, Rubula, Peribunya and Phenuiviridae (R2P2)-ReVAMPP
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Washington University United States 2024 – 2027

SUMMARY. The Vaccines and Therapeutic Antibodies to Respirovirus, Rubulavirus, Peribunyavirus and Phenuivirus (R2P2) ReVAMPP Center will utilize both well-defined and novel approac...

$441.09M
USD
Active NON-SBIR/STTR RPGS
Core A: Administrative Core
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Washington University United States 2024 – 2027

ABSTRACT – Core A: Administrative Core The Administrative Core A of the Vaccines and Therapeutic Antibodies to Respirovirus, Rubulavirus, Peribunyavirus and Phenuivirus (R2P2) ReVA...

Active NON-SBIR/STTR RPGS
Core B: Data Management Core
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Washington University United States 2024 – 2027

ABSTRACT Core B: Data Management Core Washington University (Miller, J. Philip) The overarching objective of the Data Management Core-B is to serve as the central hub for the analy...

Active NON-SBIR/STTR RPGS
Core C: Structure Core
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Washington University United States 2024 – 2027

PROJECT SUMMARY - Core C: Structure Core Structure-based vaccine antigen design is a key component of the prototype pathogen approach to pandemic preparedness. For each prototype p...

Active NON-SBIR/STTR RPGS
Core D: Antibody Core
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Washington University United States 2024 – 2027

ABSTRACT Core D: Antibody Core Washington University (Ellebedy, Ali) Respiroviruses, Rubulaviruses, Peribunyaviruses, and Phenuiviruses present major health burdens and have pandem...

Active NON-SBIR/STTR RPGS
Core E: Immunogenicity and Immune Correlates Core
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Washington University United States 2024 – 2027

ABSTRACT Core E: Immunogenicity and Immune Correlates Core (Correlates) The goal of Core E-Correlates will be to provide support to the projects by conducting various technical mea...

Active NON-SBIR/STTR RPGS
Prototype strategies for antibodies and vaccines for respiroviruses
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Washington University United States 2024 – 2027

Human parainfluenza virus type 3 (HPIV3) is the P1-Respiroviruses prototype for advancement of vaccines and therapeutic antibodies against respiroviruses due to the advanced state...

Active NON-SBIR/STTR RPGS
Prototype strategy for vaccines and antibodies to rubulaviruses
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Washington University United States 2024 – 2027

Project 2: Abstract Rubulaviruses are respiratory pathogens with a high level of transmissibility (R0 = 4-7). MuV is an ideal prototype pathogen to study paramyxoviruses because we...

Active NON-SBIR/STTR RPGS
Prototype strategy for vaccines and antibodies to Peribunyaviridae
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Washington University United States 2024 – 2027

SUMMARY. The long term goals of Project 3 of the Respiro, Rubula, Peribunya, Phenui (R2P2) ReVAMPP are to use a prototype pathogen approach to identify and validate generalizable v...

Active NON-SBIR/STTR RPGS
Design and development of generalizable countermeasures against prototype Phenuiviruses
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Washington University United States 2024 – 2027

PROJECT SUMMARY/ABSTRACT Prototype pathogens are those that, if well-characterized, can be used to develop generalizable medical countermeasures (MCMs) against new or unknown but r...

Active NON-SBIR/STTR RPGS
Core A: Administration, Communication and Project Management
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2024 – 2029

CORE A: SUMMARY/ABSTRACT This Program Project comprises four individual projects, which will: extend the WISDOM Study to evaluate the use of subtype-specific risk models and associ...

Active NON-SBIR/STTR RPGS
Project 4: CISNET Modeling of outcomes and cost for risk-based screening strategies
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2024 – 2029

Project 4 will evaluate the benefits, harms, and costs of personalized screening using one of the CISNET models of breast cancer. We will evaluate the current approaches to persona...

Active NON-SBIR/STTR RPGS
Core B: Biostatistics and Bioinformatics
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2024 – 2029

CORE B: SUMMARY/ABSTRACT The Biostatistics and Bioinformatics Core’s primary goal is to collaborate with the P01 Investigators and other Core resource scientists to ensure that res...

Active NON-SBIR/STTR RPGS
Core C : Population Genomic Risk Assessment
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2024 – 2029

CORE C: SUMMARY/ABSTRACT A polygenic risk score (PRS) combines risk information from many common genetic variants associated with a disease to predict the risk of that disease. PRS...

Active NON-SBIR/STTR RPGS
Insights into EHMT1 Variants in the Neurodevelopmental Disorder Kleefstra Syndrome through Structural Dynamics and Functional Analysis
EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD... Medical College of Wisconsin United States 2024 – 2026

Euchromatic histone methyltransferase 1 (EHMT1, also known as GLP) is a key histone methylation writer intricately associated with Kleefstra Syndrome (KS), a multifaceted neurodeve...

$4.29M
USD
Active NON-SBIR/STTR RPGS
Human Embryonic Stem Cell Models for Studying Mechanisms Underlying Changes In Inhibitory Synapses in Down Syndrome
EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD... University of Michigan At Ann Arbor United States 2024 – 2026

ABSTRACT: Down syndrome (DS), the chromosomal disorder caused by trisomy of chromosome 21 (Tri21), presents many neurological conditions, including intellectual disability (ID), au...

$4.29M
USD